Specialized Product MarketSerstech sells specialized handheld Raman chemical-ID instruments into stable, mission-critical end markets (law enforcement, customs, emergency response). Those customers value reliable identification and certification, creating durable demand, higher switching costs and repeatable after-sales/software revenue streams.

High Gross MarginsA ~70% gross margin indicates strong product-level economics from hardware and software/library sales. That margin profile can sustain R&D, maintain product differentiation and enable investment in recurring software/content, providing a structural cushion if unit volumes recover.

Low Financial LeverageWith no debt on the balance sheet, Serstech has lower refinancing risk and greater financial flexibility. This conservatism buys time to execute strategy or raise equity without imminent debt service constraints, supporting longer-term product and market development.

Bears Say

Declining RevenueSustained top-line decline (TTM down ~15%) signals weakening market traction or competitive pressure. Lower revenue undermines operating leverage for a hardware-centric business, making it harder to cover fixed R&D, manufacturing and support costs and jeopardizing long-term margin recovery.

Severe Cash BurnMaterial negative operating and free cash flow (TTM OCF ≈ -28M, FCF ≈ -31M) creates runway and funding risk. Ongoing cash burn requires external financing or dilution if losses persist, constraining strategic investments and risking interruptions to product development and customer support.

Deep Negative ProfitabilityDespite strong gross margins, the company reports steep operating and net losses (EBIT ≈ -50%, net ≈ -49%), indicating structural issues scaling the business or high operating expenses. Persistent losses erode equity, limit reinvestment capacity and increase dependency on external capital.

SERT FAQ

What was Serstech AB’s price range in the past 12 months?

Serstech AB lowest stock price was kr0.34 and its highest was kr1.03 in the past 12 months.

What is Serstech AB’s market cap?

Serstech AB’s market cap is kr93.72M.

When is Serstech AB’s upcoming earnings report date?

Serstech AB’s upcoming earnings report date is Apr 24, 2026 which is in 51 days.

How were Serstech AB’s earnings last quarter?

Serstech AB released its earnings results on Feb 27, 2026. The company reported -kr0.041 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.041.

Is Serstech AB overvalued?

According to Wall Street analysts Serstech AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Serstech AB pay dividends?

Serstech AB does not currently pay dividends.

What is Serstech AB’s EPS estimate?

Serstech AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Serstech AB have?

Serstech AB has 254,319,050 shares outstanding.

What happened to Serstech AB’s price movement after its last earnings report?

Serstech AB reported an EPS of -kr0.041 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.922%.

Which hedge fund is a major shareholder of Serstech AB?

Currently, no hedge funds are holding shares in SE:SERT

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Serstech AB

Serstech AB provides chemical identification instruments worldwide. It offers the Serstech 100 Indicator, a handheld, small, and light Raman spectrometer for measuring chemicals, such as explosives, narcotics, toxic industrial chemicals, pharmaceuticals, and chemical warfare agents; and ChemDash, a central management software for Serstech devices. The company also provides Serstech Arx and Serstech Arx+ revolutionizing instruments for quick and precise identification of chemical substances; and Serstech's SERS kit that allows for quick identification of low concentrations and narcotics samples. It offers its solutions for explosive, CBRN and hazmat, narcotics, and pharma applications. Serstech AB was incorporated in 2006 and is headquartered in Lund, Sweden.